Mechanisms in cutaneous drug hypersensitivity reactions

Cutaneous adverse drug reactions (CADRs) are considered a common problem in dermatology. They affect 2-6% of inpatients (1,2) and are a frequent cause of urgent dermatologic consultations (3). Most reactions resolve on drug suspension and symptomatic treatment but 2% can be severe with extracutaneous involvement and fatal outcome (4).